Martin Shkreli, the “pharma bro” in prison for defrauding investors, faces a lawsuit filed by the Federal Trade Commission and New York Attorney General’s office for a scheme to preserve his monopoly for the drug Daraprim, which has seen gigantic price increases.
Boeing Co has secured financing commitments for more than $12 billion from over a dozen banks, a source familiar with the matter said on Monday, as financial pressures mount due to a production halt on its 737 MAX aircraft.
As I’m sure you know, the Wuhan coronavirus is slamming the global markets.
The moment the markets opened this morning, the Dow dropped 450 points.
This sort of downside trigger catalyst came out of nowhere. Three weeks ago, you hadn’t even heard of the Wuhan coronavirus. But now it’s causing a major market sell-off.
This is typically how corrections take place. They’re unexpected. They’re sudden. And they catch everyone by surprise.
That’s exactly why I’ve been urging you here in Trade of the Day – and also in The War Room – to carry some downside protection.
On the trading floor, it’s called “cover you’re …read more […]
As concerns over the spread of the coronavirus rattle stocks, a corner of the options market is signaling that the current selloff may be short-lived.
Johnson & Johnson Chief Executive Alex Gorsky on Monday faced questions from plaintiffs lawyers over the timing of his sale of company stock, as he testified for the first time in a jury trial over allegations that the company’s Baby Powder causes cancer.
Berkshire Hathaway landed on millennials’ top 10 list of investments in the fourth quarter of 2019, according to new research. …read more […]
Stocks markets tumbled worldwide on Monday and investors worried about the possible economic impact of the coronavirus drove up the price of safe-haven assets such as the Japanese yen and government debt.
Exxon Mobil (NYSE: XOM) used to be a staple stock in many retirement portfolios. Although, renewable energy and sustainable investing growth are pushing some investors away. On top of that, energy prices have dropped and this has squeezed margins. But still, Exxon Mobil’s dividend history should continue to grow.
Cash flow remains strong and a Exxon won’t be disappearing anytime soon. Let’s take a look at the business, dividend history, and payout safety going forward.
Exxon Mobil Business
Exxon Mobil is a $278 billion dollar business. The company is based out of Texas and it employs 71,000 people. Last reported year, Exxon Mobil …read more […]
U.S. stocks fell more than 1% on Monday as investors worried about the economic impact of a virus outbreak in China as containment efforts including travel bans have been put in place in the world’s second largest economy after the country extended the Lunar New Year holiday.
The German auto supplier Webasto has halted all corporate travel to and from China because of the coronavirus outbreak and the infection of an employee, a spokeswoman for the company said on Monday.
ISRG is trading below the 80-day MA for the first time in months …read more […]
The latest rally in U.S. stocks is facing a serious test, as the S&P 500 heads toward its worst loss in months on concerns over how the coronavirus will impact the global economy.
The sixth day of President Trump’s impeachment trial in the senate is taking a new turn, as former National Security Adviser John Bolton’s upcoming book reportedly claims Trump told him to freeze aid to Ukraine, until officials helped investigate Democrats. Yahoo Finance’s Rick Newman breaks it down with Zack Guzman, Brian Cheung, and Radio Show Host, Ben Kissel. …read more […]
Jefferies’ Global Head of Microstrategy is highlighting the similarities between the SARS epidemic and the Coronavirus today. Yahoo Finance’s Zack Guzman and Brian Cheung break it down with Radio Show Host, Ben Kissel. …read more […]
I remain bullish on Aurora Cannabis (ACB) over the long term, as the company improves its cost structure while positioning itself to drive sales from derivatives in the current quarter.In this article, I want to focus on the positive growth catalysts that are visible, and where the company could surprise to the upside if the narratives plays out.The ObviousMost investors following Aurora Cannabis and other Canadian cannabis companies are aware of the limitations on their short-term growth prospects as a result of the slow licensing process in Canada and the resultant shortage of retail stores to sell cannabis out of.While …read more […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
